Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Palmetto Pharmaceuticals LLC v. AstraZeneca Pharmaceuticals, No. 16-1455 (Fed. Cir. Dec. 9, 2016)

Affirmed
Rule 36 Affirmance
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 16-1455
Also Docketed
No. 16-1501 (consolidated; same document)
Decided
December 9, 2016
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages
Download Opinion (PDF)

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit PALMETTO PHARMACEUTICALS LLC,

Plaintiff-Appellant

v.

ASTRAZENECA PHARMACEUTICALS LP,

Defendant-Cross-Appellant

2016-1455, 2016-1501

Appeals from the United States District Court for the District of South Carolina in No. 2:11-cv-00807-SB, Senior Judge Solomon Blatt, Jr.

JUDGMENT

JOHN PAUL ISACSON, Perkins Coie, LLP, Washington, DC, argued for plaintiff-appellant. Also represented BY COLIN GENE SANDERCOCK; DAVID J. HARTH, DAVID R. PEKAREK KROHN, JOHN SINGLETON SKILTON, Madison, WI; DAN L. BAGATELL, Hanover, NH.

CHRISTOPHER NEIL SIPES, Covington & Burling LLP, Washington, DC, argued for defendant-cross-appellant. Also represented by STEPHEN PIERCE ANTHONY, ISAAC CHAIM BELFER, ROBERT JASON FOWLER.

2THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (MOORE, WALLACH, and CHEN, Circuit

Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT December 9, 2016 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Palmetto Pharmaceuticals LLC v. AstraZeneca Pharmaceuticals, No. 16-1455 (Fed. Cir. Dec. 9, 2016).

govinfo ID
USCOURTS-ca13-16-01455-0
Permalink
https://patentcasewatch.com/opinions/USCOURTS-ca13-16-01455-0

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: govinfo.gov USCOURTS collection · retrieved July 25, 2026 · Report an error